Martha Arellano

ORCID: 0000-0003-1636-1962

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia”.

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

Nature(2023)10.1038/s41586-023-05812-3

N/A

5.2DataRank · unranked

480 citations

Ibrahim Aldoss, John F. Dipersio, Branko Cuglievan, Richard M. Stone, Martha Arellano +19 more

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Blood(2020)10.1182/blood.2020007732

N/A

4.0DataRank · unranked

322 citations

Ibrahim Aldoss, Matthew C. Foster, Peter H. Sayre, Matthew J. Wieduwilt, Anjali S. Advani +43 more

TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

Blood Advances(2020)10.1182/bloodadvances.2020002512

N/A

3.8DataRank · unranked

155 citations

Catherine Lai, Stephen Reeder, S. Church, Tressa Hood, Anbarasu Lourdusamy +24 more

Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cells

Molecular Cell(2021)10.1016/j.molcel.2021.06.027

N/A

1.0DataRank · unranked

24 citations

Siyuan Xia, Rukang Zhang, Yuancheng Li, Christopher Famulare, Hao Fan +20 more

Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates

Blood Advances(2022)10.1182/bloodadvances.2022008625

N/A

0.839DataRank · unranked

19 citations

Scott H. Kaufmann, Eytan M. Stein, Prapti A. Patel, Maria R. Baer, Wendy Stock +35 more

Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia

Blood Advances(2020)10.1182/bloodadvances.2019001126

N/A

0.601DataRank · unranked

54 citations

Soyoung Kim, Heather R. Tecca, Stephanie Bo‐Subait, Rachel Phelan, Ruta Brazauskas +33 more